Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(1):4-17
Patients undergoing cytotoxic chemotherapy and hematopoietic stem-cell transplantation are at risk for infection. The risk of infections increases with the depth and duration of neutropenia, with the greatest risk occurring in patients who experience …